Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Filed with BSE · ISIN INE552U01010 · · 2 pages · English
Kwality Pharmaceuticals Ltd on 6ix
In the deck
Story so far
Earlier from Kwality Pharmaceuticals
- Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026.
- EU-GMP Approval From Hungary For Cephalosporin And Oncology Facilities
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Kwality Pharmaceuticals Ltd Press Release Sep 28 2026
- Kwality Pharmaceuticals Ltd Press Release Aug 31 2026
Later from Kwality Pharmaceuticals
All Kwality Pharmaceuticals news releasesFollow Kwality Pharmaceuticals into a list and get an email when it puts out news.
Follow Kwality Pharmaceuticals